Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort

Background/Aims: This study evaluated the long-term cardiovascular complications among Korean patients with hyperten-sion and compared them with that of controls without hypertension. Methods: The Korean Hypertension Cohort (KHC) enrolled 11,043 patients with hypertension and followed them for more than 10 years. Age-and sex-matched controls without hypertension were enrolled at a 1:10 ratio. We compared the inci-dence of cardiovascular events and death among patients and controls without hypertension. Results: The mean age was 59 years, and 34.8% and 16.5% of the patients belonged to the high and moderate cardiovas-cular risk groups, respectively. During the 10-year follow-up, 1,591 cardiovascular events (14.4%) with 588 deaths (5.3%) oc-curred among patients with hypertension and 7,635 cardiovascular events (6.9%) with 4,826 deaths (4.4%) occurred among controls. Even the low-risk population with hypertension showed a higher cardiovascular event rate than the population without hypertension. Although blood pressure measurements in the clinic showed remarkable inaccuracy compared with those measured in the national health examinations, systolic blood pressure (SBP) >= 150 mmHg was significantly associated with a higher risk of cardiovascular events. Conclusions: This long-term follow-up study confirmed the cardiovascular event rates among Korean hypertensive patients were substantial, reaching 15% in 10 years. SBP levels >= 150 mmHg were highly associated with occurrence of cardiovascular event rates.

Automated summary

This study evaluated the long-term cardiovascular complications among Korean patients with hypertension and compared them with that of controls without hypertension. The results showed that the cardiovascular event rates were higher among patients with hypertension, even in low-risk populations. Systolic blood pressure levels >= 150 mmHg were significantly associated with the occurrence of cardiovascular events.